About
Ophthalmology Drugs
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
625
By Phase
PHASE3: 2NA: 1
By Status
UNKNOWN: 2SUSPENDED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Today
Hover over trial bars to see details
Recent Trials
NCT00460967Lead Sponsor
Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis
PHASE3Suspended
325 participants
Started: Jan 31, 2007 · Completed: Dec 31, 2009
NCT00380172Lead Sponsor
Long-Term Efficacy in AMD of Rheopheresis in North America
NAUnknown
120 participants
Started: Oct 31, 2005 · Completed: Oct 31, 2007
NCT00078221Lead Sponsor
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
PHASE3Unknown
180 participants
Started: Aug 31, 1999 · Completed: Dec 31, 2005
Locations (1)
Headquarters
Pittsburgh, PA, United States
Map
Loading map...